Physician

Yue Wang, M.D.

According to 2025 Medicare claims, Yue Wang, M.D. (NPI: 1225143134) practices internal medicine in the Trenton-Princeton, NJ market, with the plurality of this provider's patient population coming from Mercer, NJ. This provider's primary affiliated billing organization is YUE WANG, MD, LLC (NPI: 1467501809; TIN: 205197927) and primary practice location at 08690-1708.

Wang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 515 traditional Medicare patients, billed 6,161 HCPCS/CPT codes, and received $520,163 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 12,594 prescription claims across 564 beneficiaries totaling $2,165,127 in drug costs, led by Jardiance (Empagliflozin). DME data shows 149 claims. Open Payments data shows 48 records totaling $1,728. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $694,281 to $520,163. In contrast, Part D prescription costs have risen steadily, from $1,148,833 to $2,165,127. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $29,371 and ending at $22,213.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	724	19,160	$694,281
2016	719	21,413	$841,787
2017	658	18,843	$815,412
2018	642	15,252	$748,038
2019	711	13,576	$805,067
2020	575	6,287	$397,165
2021	539	5,614	$394,852
2022	537	5,596	$427,085
2023	482	5,749	$465,013
2024	515	6,161	$520,163

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	515	10,454	$1,148,833
2016	621	15,520	$1,656,599
2017	649	18,145	$2,137,373
2018	687	19,130	$2,420,565
2019	718	19,459	$2,560,910
2020	652	16,159	$2,349,181
2021	619	14,475	$2,351,007
2022	581	13,721	$2,320,587
2023	529	12,747	$2,456,512
2024	564	12,594	$2,165,127

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	211	484	$19,313
2016	238	576	$28,193
2017	129	506	$14,960
2018	224	595	$33,999
2019	146	506	$14,207
2020	137	490	$13,713
2021	122	515	$16,448
2022	84	412	$10,281
2023	58	234	$9,749
2024	43	149	$10,981

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	159	194	$142
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	139	139	$136
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	173	893	$99
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	231	1,004	$97
99239	Hospital discharge day management, more than 30 minutes	171	221	$94

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	218	11,772	$219,180
Farxiga	Dapagliflozin Propanediol	229	11,907	$212,078
Ozempic	Semaglutide	81	4,488	$143,064
Trulicity	Dulaglutide	79	3,827	$123,340
Eliquis	Apixaban	217	6,215	$118,043

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	19	$9,231
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	28	67	$1,103
A4314	Insertion tray with drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.)	N	N/R	13	$334
K0001	Standard wheelchair	Y	N/R	11	$147
A4357	Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each	N	N/R	13	$128

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	48	$1,728	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Yue Wang, M.D.?

Tedicare shows public-source Medicare data for Yue Wang, M.D. (NPI 1225143134), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Yue Wang, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Yue Wang, M.D.?

Yue Wang, M.D. is linked to YUE WANG, MD, LLC (billing NPI 1467501809) in the available physician profile data.

Does Yue Wang, M.D. have Open Payments data?

Yue Wang, M.D. has 48 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.